Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Novartis ends BioArctic pact; Two VC firms raise inaugural funds

Plus news about Teva, Ultragenyx and Specific Biologics. Novartis cans BioArctic collab: The Swiss pharma axed its discovery-stage work with the Swedish biotech, which created the Alzheimer’s drug Leqembi. The neurodegeneration-focused ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Tuesday 3 November →